BioMap
BioMap valuation and funding history | Last updated: June 24, 2024
Current Valuation
N/A
As of June 24, 2024
Total Funding Raised
$100.0M
Last Round
Early Stage VC
Amount undisclosed
Last Funding
Jun 2024
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
No funding history available
Funding data has not been imported for this company yet
Valuation Analysis
Current Valuation Metrics
BioMap is currently valued at N/A as of June 24, 2024. The company has raised a total of $100.0M in funding.
What is BioMap Worth in 2026?
BioMap is a leading private company in the technology sector. Track BioMap's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How BioMap Valuation is Determined
Private company valuations like BioMap's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.